---
title: "CHISON MEDICAL: Net profit in the third quarter was 24.2241 million yuan, a year-on-year increase of 41.95%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261766432.md"
description: "CHISON MEDICAL announced that its revenue for the third quarter was 107 million yuan, a year-on-year decrease of 6.68%; net profit was 24.2241 million yuan, a year-on-year increase of 41.95%. Revenue for the first three quarters was 343 million yuan, a year-on-year decrease of 5.27%; net profit was 93.9205 million yuan, a year-on-year decrease of 4.56%"
datetime: "2025-10-19T10:15:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261766432.md)
  - [en](https://longbridge.com/en/news/261766432.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261766432.md)
generator: "portal-rs"
---

# CHISON MEDICAL: Net profit in the third quarter was 24.2241 million yuan, a year-on-year increase of 41.95%

CHISON MEDICAL announced that its revenue for the third quarter was 107 million yuan, a year-on-year decrease of 6.68%; net profit was 24.2241 million yuan, a year-on-year increase of 41.95%. Revenue for the first three quarters was 343 million yuan, a year-on-year decrease of 5.27%; net profit was 93.9205 million yuan, a year-on-year decrease of 4.56%

### Related Stocks

- [688358.CN](https://longbridge.com/en/quote/688358.CN.md)

## Related News & Research

- [08:27 ETClose O Matic's Step Six: How AI Sales Conversations Become Closed Sales](https://longbridge.com/en/news/297517308.md)
- [10:12 ETOnymos and Vanta Diagnostics Collaborate to Scale Intelligent Lab Intake](https://longbridge.com/en/news/297799488.md)
- [Reallusion AI Studio 1.1 Major Update: Standalone Application, Seedance 2.5, and Upgraded AI Actor Creator](https://longbridge.com/en/news/297783180.md)
- [Galenica expands Swiss pharmacy network with Bären Apotheke Zytglogge acquisition in Bern](https://longbridge.com/en/news/297732987.md)
- [ChatGPT Health adds Epic integration for clinicians to import patient data](https://longbridge.com/en/news/297680881.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**